Taken together, our study demonstrated that oridonin inhibited tumor growth with high safety by inducing apoptosis through activating PPAR-γ and inhibiting Nrf2 signaling pathway in human osteosarcoma. This evidence concerns the gene NFE2L2 and neoplasm.